Delivery Order SPE2DR25D3108-SPE2DR26F1PWS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,706.84 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Journavx 50 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 7, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,136.12 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Journavx 50 mg tablets (30-count packaging). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,536.24 to AmerisourceBergen Drug Corp for the supply of Journavx 50 mg tablets (30-count units) under a firm fixed price contract. The award was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $6,943.92 to AmerisourceBergen Drug Corp for the supply of JOURNAVX 50 MG tablets (30-count units) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $12,518.12 to AmerisourceBergen Drug Corp for Journavx 50 mg tablets (30-count packaging) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Journavx 50 mg tablets in unit dose packaging (100 count) under a firm fixed price contract valued at $1,239.88. This delivery order, issued on October 29, 2025, represents a child contract under the larger Indefinite Delivery Contract vehicle and requires completion by October 30, 2025. The award was made through open competition with no set-aside designation, demonstrating the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Journavx 50 mg tablets in unit dose packaging (100 count). This is a firm fixed-price delivery order with a ceiling value of $3,305.43, with an ultimate completion date of July 1, 2025. The award utilizes no set-aside designation and represents a competitively awarded contract. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,617.76 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Journavx 50 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation and specifies...
- This delivery order, valued at $5,998.20, was awarded to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Journavx 50 mg tablets (30-count units) to support federal medical procurement needs. The contract represents a non-competitive, firm fixed-price delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December...
- This delivery order, awarded to AmerisourceBergen Drug Corp on November 12, 2025, provides for the supply of Journavx 50 mg tablets (30-count units) with a ceiling value of $14,471.04 under firm fixed-price terms. The award is not set-aside and represents a competitive procurement by the Defense Logistics Agency, a component of the Department of Defense responsible for managing the supply chain for military and federal healthcare systems. The place of performance is AmerisourceBergen's corporate...
- SPE2DR25D3108Indefinite Delivery Contract
- SPE2DR25D3108-SPE2DR26F1PWSDelivery Order
The Defense Logistics Agency awarded a $2,248.02 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Journavx 50 mg, with a firm fixed price contract type. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a non-set-aside contract awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and related supplies across multiple therapeutic domains. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills federal medical procurement needs for military and veteran healthcare systems through competitively awarded delivery orders under this strategic contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/16/25 |